Faculty of Biological and Environmental Sciences, Molecular and Integrative Bioscience Research Programme, University of Helsinki, Helsinki, Finland
Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01597-18. Print 2019 Feb 15.
Human parechovirus 3 (HPeV3) infection is associated with sepsis characterized by significant immune activation and subsequent tissue damage in neonates. Strategies to limit infection have been unsuccessful due to inadequate molecular diagnostic tools for early detection and the lack of a vaccine or specific antiviral therapy. Toward the latter, we present a 2.8-Å-resolution structure of HPeV3 in complex with fragments from a neutralizing human monoclonal antibody, AT12-015, using cryo-electron microscopy (cryo-EM) and image reconstruction. Modeling revealed that the epitope extends across neighboring asymmetric units with contributions from capsid proteins VP0, VP1, and VP3. Antibody decoration was found to block binding of HPeV3 to cultured cells. Additionally, at high resolution, it was possible to model a stretch of RNA inside the virion and, from this, identify the key features that drive and stabilize protein-RNA association during assembly. Human parechovirus 3 (HPeV3) is receiving increasing attention as a prevalent cause of sepsis-like symptoms in neonates, for which, despite the severity of disease, there are no effective treatments available. Structural and molecular insights into virus neutralization are urgently needed, especially as clinical cases are on the rise. Toward this goal, we present the first structure of HPeV3 in complex with fragments from a neutralizing monoclonal antibody. At high resolution, it was possible to precisely define the epitope that, when targeted, prevents virions from binding to cells. Such an atomic-level description is useful for understanding host-pathogen interactions and viral pathogenesis mechanisms and for finding potential cures for infection and disease.
人肠道病毒 3(HPeV3)感染与败血症有关,其特征是新生儿存在显著的免疫激活和随后的组织损伤。由于缺乏用于早期检测的分子诊断工具以及缺乏疫苗或特定的抗病毒治疗,限制感染的策略尚未成功。针对后者,我们使用冷冻电镜(cryo-EM)和图像重建技术,获得了 HPeV3 与中和人源单克隆抗体 AT12-015 的片段复合物的 2.8Å 分辨率结构。建模表明,表位跨越相邻的不对称单元延伸,来自衣壳蛋白 VP0、VP1 和 VP3。抗体修饰被发现可阻止 HPeV3 与培养细胞的结合。此外,在高分辨率下,有可能对病毒粒子内的 RNA 进行建模,并由此确定在组装过程中驱动和稳定蛋白-RNA 结合的关键特征。人肠道病毒 3(HPeV3)作为导致新生儿类似败血症症状的主要原因,越来越受到关注,尽管疾病严重,但目前尚无有效的治疗方法。迫切需要对病毒中和的结构和分子有深入的了解,特别是随着临床病例的增加。为此,我们展示了 HPeV3 与中和单克隆抗体片段复合物的首个结构。在高分辨率下,有可能精确地确定表位,当靶向该表位时,可防止病毒粒子与细胞结合。这种原子水平的描述对于理解宿主-病原体相互作用和病毒发病机制以及寻找感染和疾病的潜在治疗方法非常有用。